Class Action Complaint Says Nasal Decongestant Makers Misrepresented Efficacy
September 15, 2023
DOCUMENTS
- Complaint
PENSACOLA, Fla. — A Florida man has filed a federal class action against Procter & Gamble and Johnson & Johnson Consumer Inc., alleging the active ingredient, phenylephrine, in their popular over-the-counter oral nasal decongestants did not work as advertised.
The Sept. 13 complaint filed in the U.S. District Court for the Northern District of Florida seeks refunds on behalf of two groups of consumers who he says suffered economic damages after buying Sudafed PE, Vicks NyQuil, and Benadryl Allergy Plus Congestion.
Steve Audelo filed the complaint after a Food and Drug Administration panel stated that phenylephrine, when taken orally, …
UPCOMING CONFERENCES

HarrisMartin’s Benzene and Toxic Tort Litigation Conference: Recent Developments and Future Trends
December 01, 2023 - Charleston, SC
The Charleston Place